Clinical Trial Update: Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating lamivudine in combination with chemoimmunotherapy for extensive-stage small cell lung cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Extensive Stage Lung Small Cell Carcinoma | Phase 2 | Status: RECRUITING